EATG » Access

Access

Europe’s life science industry urges the UK and EU27 to safeguard patients’ access to medicines after Brexit

Europe’s life science industry urges the UK and EU27 to safeguard patients’ access to medicines with a clear transition period and a future cooperation agreement after Brexit The associations representing…

Medicines Excitement in the Netherlands – New Health Minister announces firm action on “absurd” medicines pricing and gets the European Medicines Agency

November 24, 2017: The new Minister of Health of the Netherlands, Bruno Bruins, came in guns blazing when he put the pharmaceutical industry on notice and announced on 22 November…

Open letter to the Romanian MoH to focus on TB

The Romanian Health Observatory, supported by the Romanian Angel Appeal Foundation (RAA) under the Global Fund programme, has published “The Crisis of Anti-TB Medicines in Romania”, a comprehensive and evidence-based…

Danish court invalidates Gilead SPC

The Danish Maritime and Commercial High Court has invalidated a supplementary protection certificate (SPC) owned by Gilead. On October 26, the court rejected Gilead’s motion for an injunction against generics…

Hepatitis C buyers’ clubs grow worldwide as a way to obtain affordable treatment

Hidden amongst the thousands of Facebook pages given over to holiday snaps and gossip are groups of patients who have hepatitis C, a disease that affects more than 70 million…

MPP and USAID sign Memorandum of Understanding

Geneva, 02 November 2017 — The Medicines Patent Pool and the United States Agency for International Development (USAID) signed a Memorandum of Understanding (MoU) to accelerate the introduction of quality,…

Report: TB medicine crisis in Romania

Authorities in Romania are unable to provide the full range of essential medicines needed for the treatment of TB, the Romanian Health Observatory said in its latest report, TB medicine…

MSF secures generic hepatitis C treatment at $120 compared to $147,000 launch price tag

Geneva/Sao Paolo, 31 October 2017—On the eve of the World Hepatitis Summit in Sao Paolo, the international medical humanitarian organization Médecins Sans Frontières (MSF) today announced that it had secured…

Health group challenges Gilead patents in the US on grounds of lack of novelty

A health advocacy group today (October 25) announced that it has challenged a set of United States patents for a hepatitis C medicine. The group says drug maker Gilead Sciences…

Tivicay® and Celsentri® now included in the Essential Drug List in Russia

Both medicines expected to be available in HIV specialist treatment centers from 2018 onwards. London, UK, Tuesday 24 October, 2017 – ViiV Healthcare, a global specialist HIV company with GSK,…